Laboratory Corporation of America Holdings Management
Management criteria checks 4/4
Laboratory of America Holdings' CEO is Adam Schechter, appointed in Nov 2019, has a tenure of 4.42 years. total yearly compensation is $15.98M, comprised of 8.6% salary and 91.4% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth $19.47M. The average tenure of the management team and the board of directors is 4.3 years and 10.2 years respectively.
Key information
Adam Schechter
Chief executive officer
US$16.0m
Total compensation
| CEO salary percentage | 8.6% |
| CEO tenure | 4.4yrs |
| CEO ownership | 0.1% |
| Management average tenure | 4.3yrs |
| Board average tenure | 10.2yrs |
Recent management updates
Recent updates
Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Apr 15
Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark
Apr 06Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear
Apr 01Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Feb 25We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings
Feb 22An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued
Feb 21Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72
Jan 31Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 30Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72
Jan 15Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio
Jan 05Laboratory Corporation: Multiple Updates, Same Investment Conclusion
Dec 02Laboratory Corp.: Rate On Capital Deployed Contracting, Hold
Sep 14Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
Jul 05Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts
Jul 04Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?
Jun 23Laboratory Corporation: Predictability Of Cash Flows Less Visible
Jun 21Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher
Mar 16Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate
Mar 02Laboratory Corporation of America Non-GAAP EPS of $4.14 in-line, revenue of $3.7B misses by $40M, introduces FY23 outlook
Feb 16At US$254, Is It Time To Put Laboratory Corporation of America Holdings (NYSE:LH) On Your Watch List?
Jan 30Laboratory Corporation: Plenty Of Growth Runway
Jan 19Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 16Laboratory Corporation of America declares $0.72 dividend
Jan 12Returns At Laboratory Corporation of America Holdings (NYSE:LH) Are On The Way Up
Dec 07Is There An Opportunity With Laboratory Corporation of America Holdings' (NYSE:LH) 25% Undervaluation?
Nov 24Laboratory Corporation: Buy Rating Holds Following Solid Mid-Level Growth
Nov 08Laboratory Corporation of America Q3 2022 Earnings Preview
Oct 26We Think Laboratory Corporation of America Holdings (NYSE:LH) Can Stay On Top Of Its Debt
Oct 14Laboratory Corporation of America declares $0.72 dividend
Oct 12Is Laboratory Corporation of America Holdings (NYSE:LH) Potentially Undervalued?
Sep 28LabCorp to pay $273M to company for infringing prenatal test patents - Bloomberg
Sep 23LabCorp: Drug Development Segment Spinoff Poised To Generate Significant Value
Aug 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$16m | US$1m | US$379m |
| Sep 30 2023 | n/a | n/a | US$860m |
| Jun 30 2023 | n/a | n/a | US$954m |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$15m | US$1m | US$1b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$21m | US$1m | US$2b |
| Sep 30 2021 | n/a | n/a | US$3b |
| Jun 30 2021 | n/a | n/a | US$3b |
| Mar 31 2021 | n/a | n/a | US$3b |
| Dec 31 2020 | US$15m | US$1m | US$2b |
| Sep 30 2020 | n/a | n/a | US$845m |
| Jun 30 2020 | n/a | n/a | US$362m |
| Mar 31 2020 | n/a | n/a | US$321m |
| Dec 31 2019 | US$6m | US$208k | US$824m |
| Sep 30 2019 | n/a | n/a | US$755m |
| Jun 30 2019 | n/a | n/a | US$853m |
| Mar 31 2019 | n/a | n/a | US$896m |
| Dec 31 2018 | US$301k | n/a | US$884m |
| Sep 30 2018 | n/a | n/a | US$1b |
| Jun 30 2018 | n/a | n/a | US$1b |
| Mar 31 2018 | n/a | n/a | US$1b |
| Dec 31 2017 | US$290k | n/a | US$1b |
Compensation vs Market: Adam's total compensation ($USD15.98M) is about average for companies of similar size in the US market ($USD13.51M).
Compensation vs Earnings: Adam's compensation has been consistent with company performance over the past year.
CEO
Adam Schechter (58 yo)
4.4yrs
Tenure
US$15,979,355
Compensation
Mr. Adam H. Schechter serves as President & Chief Executive Officer at Laboratory Corporation of America Holdings since November 01, 2019 and serves as its Chairman since May 13, 2020. He serves as Indepen...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.4yrs | US$15.98m | 0.11% $ 19.5m | |
| CFO & Executive VP | 9.8yrs | US$4.96m | 0.048% $ 8.4m | |
| Executive VP | less than a year | US$3.80m | 0.0060% $ 1.0m | |
| EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | less than a year | US$3.48m | 0.033% $ 5.8m | |
| Executive VP & Chief Human Resources Officer | 1.3yrs | US$2.56m | 0.00035% $ 61.2k | |
| Senior VP & Chief Accounting Officer | 5yrs | no data | 0.0054% $ 941.3k | |
| Executive VP and Chief Information & Technology Officer | 10.2yrs | US$2.70m | 0.033% $ 5.8m | |
| Vice President of Investor Relations | no data | no data | no data | |
| Executive VP | 5.2yrs | no data | 0.0091% $ 1.6m | |
| Executive VP & Chief Marketing Officer | 4.1yrs | no data | 0.0047% $ 827.5k | |
| Enterprise Chief Scientific Officer & Senior VP | no data | no data | no data | |
| Chief Medical Officer | 3.3yrs | no data | no data |
4.3yrs
Average Tenure
59yo
Average Age
Experienced Management: LH's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 11yrs | US$15.98m | 0.11% $ 19.5m | |
| Independent Director | 11.3yrs | US$384.99k | 0.014% $ 2.5m | |
| Independent Director | 17.9yrs | US$340.73k | 0.020% $ 3.4m | |
| Independent Director | 29yrs | US$330.31k | 0.021% $ 3.7m | |
| Lead Independent Director | 10.3yrs | US$339.99k | 0.014% $ 2.5m | |
| Independent Director | 8.2yrs | US$319.99k | 0.010% $ 1.8m | |
| Independent Director | 16.9yrs | US$350.01k | 0.0097% $ 1.7m | |
| Independent Director | 10yrs | US$330.01k | 0.010% $ 1.8m | |
| Independent Director | 4.3yrs | US$344.30k | 0.0043% $ 752.3k | |
| Director | less than a year | US$208.42k | 0.000020% $ 3.5k | |
| Independent Director | 3.1yrs | US$330.01k | 0.0027% $ 475.9k | |
| Independent Director | 1.5yrs | US$330.01k | 0.0016% $ 274.7k |
10.2yrs
Average Tenure
62.5yo
Average Age
Experienced Board: LH's board of directors are seasoned and experienced ( 10.2 years average tenure).